Developer docs
API playgroundTry for free, no card

Search company profiles

PEPID

Full company profile

uuid000bi5b

Namestring
PEPID
Legal namestring
PEPID, LLC
Websiteurl
pepid.com
Company typeenum
Private
Founded yearint
1994
Descriptiontext

PEPID (PEPID, LLC) is a privately held clinical decision support and medical reference software company founded in 1994 by Dr. Mark Rosenbloom and headquartered in Evanston, Illinois. The company provides healthcare professionals — including emergency physicians, nurses, pharmacists, nurse practitioners, EMTs/paramedics, medical students, and residents — with point-of-care access to a curated clinical content platform comprising the PEPID Knowledgebase (PKB) drug database (13,000+ drug names covering U.S. and Canadian trade names, generics, OTCs, herbals, and supplements, cross-referenced against 100,000+ drug products and 900+ nutraceuticals), 3,000+ dosing and IV-drip calculators, 800+ medical calculators/scores, a 200+ entry lab manual, 750+ procedural videos, 1,800+ medical illustrations, 1,200+ radiographic images, a differential diagnosis generator, pill identifier, and IV compatibility checker. PEPID's content is peer-reviewed by an advisory board of 35+ board-certified physicians and pharmacologists and is produced in partnership with U.S. medical societies including ASHP, ACEP, AAEM, NAEMSE, NACNS, ONS, FPIN, and BEEM, with approximately 44% of content refreshed each calendar quarter.

The platform is delivered through three distribution channels: direct subscriptions via the PEPID Connect web portal, native iOS and Android mobile apps, and the Backbone by PEPID API layer for embedding drug interaction, IV compatibility, and clinical content into third-party EMR, EHR, HIS, HIE, and patient portal systems. Revenue is generated through individual professional subscriptions priced in the $100–$300 annual range (1-/2-/3-year tiers), lower-priced student and resident monthly tiers ($8–$25/month), add-on modules such as Patient Medication Education, Bedside Education, and PEPID CME, and undisclosed institutional volume licensing plus OEM/API licensing economics. The company markets primarily via a product-led growth motion (2-week free trials across all suites) supplemented by institutional sales outreach and society-driven brand endorsement, and reports reach across thousands of institutions in 159 countries. Leadership consists of founder-CEO Dr. Mark Rosenbloom, who also serves as Editorial Director, and CTO Edward Reynolds; the company has no disclosed external funding rounds and operates with an 11–50 person headcount.

Short descriptiontext

PEPID is a privately held clinical decision support and medical reference software company that sells specialty drug databases, calculators, and clinical content subscriptions to healthcare professionals, students, and institutions across 159 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPhoenix, United States
HQ citystring
Phoenix
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical decision support, drug interaction checking, medical reference software, healthcare point-of-care, clinical calculators
Industry1 code
PRIMARYHLACAKAC
Pharmacy Information Systems (PIS) & Dispensing Workflow
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Decision Support Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Individual Subscriptions
TypeSubscription Recurring
Description

Subscription-based model with annual, 2-year, and 3-year billing options for individual healthcare professionals across various specialties including emergency medicine, nursing, pharmacy, and primary care.

pepid.com
2Institutional Licenses
TypeSubscription Recurring
Description

Volume-based institutional subscriptions for hospitals, health systems, and educational institutions with shared logins, IP authentication, or individual login options supporting unlimited concurrent users.

pepid.com
3API/Integration Licensing
TypeLicensing Royalties
Description

Backbone by PEPID provides drug database and clinical content integration into EMR, EHR, HIS, and other health IT systems through API licensing.

pepid.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components2 values
Personnel, Technology or R&D
Pricing details11 tiers
1Emergency Medicine Suite - Individual subscription for emergency physicians
ModelSubscriptionBilling cadenceAnnual
Notes

1-Year: $299.95 billed annually; 2-Year: $549.90 billed every 2 years; 3-Year: $774.85 billed every 3 years. Mobile (iPhone, Android, iPad) and Online access available.

pepid.com
2Pediatric Emergency Medicine Suite
ModelSubscriptionBilling cadenceAnnual
Notes

1-Year: $299.95/year; 2-Year: $549.90/2-years; 3-Year: $774.85/3-years

pepid.com
3Pharmacist Pro with AHFS
ModelSubscriptionBilling cadenceAnnual
Notes

1-Year: $254.95/year; 2-Year: $459.90/2-years; 3-Year: $639.85/3-years

pepid.com
4EMS Plus NAEMSE - For EMTs and paramedics
ModelSubscriptionBilling cadenceAnnual
Notes

1-Year Mobile & Tablet: $104.95/year; 2-Year: $159.90/2-years; 3-Year: $185.85/3-years; Online 1-Year: $159.95/year

pepid.com
5RN Student Clinical Companion
ModelSubscriptionBilling cadenceMonthly
Notes

1-Year: $16.25/month billed annually ($195/year); 2-Year: $14.16/month; 3-Year: $12.77/month

pepid.com
6Emergency Medicine - Resident/Monthly pricing
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly: $9.99/month; Annual: $99.90/year ($8.33/month). Use codes RESIDENT15 for 15% off or RESIDENT200 for $200 discount.

7Patient Medication Education Add-on
ModelSubscriptionBilling cadenceMonthly
Notes

$6.25/month billed annually, 2-year, or 3-year. Available exclusively for PEPID Connect.

pepid.com
8Bedside Education Add-on
ModelSubscriptionBilling cadenceAnnual
Notes

$125/year billed annually, 2-year, or 3-year. Can be added to any PEPID subscription.

pepid.com
9AHFS Drug Information Essentials by PEPID
ModelSubscriptionBilling cadenceMonthly
Notes

1-Year: $22.91/month; 2-Year: $20.83/month; 3-Year: $18.05/month

pepid.com
10RN Care Plan Pro
ModelSubscriptionBilling cadenceMonthly
Notes

$8.25/month billed annually, 2-year, or 3-year

pepid.com
11Clinical Rotation Companion for Medical Students
ModelSubscriptionBilling cadenceMonthly
Notes

1-Year: $25/month; 2-Year: $22.91/month; 3-Year: $21.52/month

pepid.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 5 records shown
1PEPID Connect
Description

Online clinical decision support platform accessible from any PC or Apple computer with automatic content updates

pepid.com
+4 more records
Core offering1 text field

PEPID provides web-based and mobile point-of-care clinical decision support tools and drug information resources for healthcare professionals, institutions, and students. Its portfolio includes specialty medical suites (emergency medicine, nursing, pharmacy, primary care, EMS), clinical tools such as drug interaction checkers and dosing calculators, and the Backbone API platform for integrating clinical content into EMR/EHR systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • PEPID's Drug Interactions Checker is backed by the PEPID Knowledgebase (PKB) which houses the largest drug database on the market, continuously reviewed and updated in close partnership with ASHP
+2 more records
Product overview1 text field

PEPID offers a comprehensive clinical decision support platform comprising multiple specialized product suites for healthcare professionals across various medical specialties. The portfolio includes: EM Complete (new flagship combining adult and pediatric emergency medicine with integrated CME), Emergency Medicine Suite, Pediatric Emergency Medicine Suite, Primary Care Plus Ambulatory Care, Professional Nursing Suite, Critical Care Nursing Suite, Oncology Nursing Suite, Gerontological Nursing Suite, Clinical Rotation Companion, RN Student Clinical Companion, RN Care Plan Pro, Pharmacist Pro with AHFS, AHFS Drug Information Essentials, Portable Drug Companion, and EMS Plus NAEMSE. Supporting modules include Bedside Education, Patient Medication Education, and PEPID CME. Core tools and features include Drug Interactions Checker, IV Compatibility Checker, Dosing & Medical Calculators, Pill Identifier, Lab Manual, Medical Videos (750+), Illustrations & Radiographic Images (1,800+ illustrations, 1,200+ images), Notes & Favorites, and Differential Diagnosis Generator. Access is available via PEPID Connect (online), mobile apps (iOS/Android), and system integration through Backbone by PEPID. Founded in 1994, PEPID maintains approximately 44% content updates quarterly through an aggressive editorial cycle with peer-reviewed content from board-certified specialists.

Product and service1 record
1Emergency Medicine Suite
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1American College of Emergency Physicians (ACEP)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ACEP is a content partnership providing evidence-based essentials, guidelines, and high-resolution multimedia for PEPID's emergency medicine databases and suites.

pepid.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AAEM provides content partnership for emergency medicine reference materials, protocols, and evidence-based guidelines integrated into PEPID's clinical decision support suites.

3American Society of Health Systems Pharmacists (ASHP)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ASHP partnership provides the foundation for PEPID's industry-leading drug database with continuous review and updates to ensure accuracy and comprehensiveness of drug information.

pepid.com
4National Association of EMS Educators (NAEMSE)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NAEMSE collaborated with PEPID to develop EMS Plus NAEMSE, providing complete emergency medicine reference, drug database with toxicology section, emergency protocols and evidence-based information specifically designed for pre-hospital emergency care providers.

pepid.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NACNS partnered with PEPID to develop specialized nursing suites including Critical Care Nursing Suite (RNCC) and Gerontological Nursing Suite (RN Gero), providing evidence-based considerations and specialized content for clinical nurse specialists.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ONS developed PEPID Oncology Nursing Suite (RN ONS) to simplify complex cancer care and strengthen evidence-based nursing with the latest PEP cards, NANDA-I considerations, drug information, and clinical content.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

FPIN provides the latest peer-reviewed Clinical Inquiries and PURLs integrated into PEPID's Primary Care Plus and Clinical Rotation Companion suites for evidence-based clinical decision support.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

BEEM provides evidence-based essentials and guidelines integrated into PEPID's emergency medicine and pediatric emergency medicine databases.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Wolters Kluwer's evidence-based clinical decision support platform serving physicians, nurses, and healthcare professionals across specialties with similar point-of-care content and drug reference functionality.

TypeDirect peer
Description

WebMD's free clinical reference platform offering drug information, clinical calculators, and decision support to physicians, with overlapping user base and similar point-of-care use cases despite free/ad-supported model.

TypeEmerging player
Description

AI-native clinical decision support platform using large language models for medical reference, representing the emerging conversational AI threat to traditional content-database CDS tools like PEPID.

TypeEmerging player
Description

Differential diagnosis decision support tool that directly competes with PEPID's Differential Diagnosis Generator (DDx) functionality, focused on accelerating diagnostic accuracy for clinicians at point-of-care.

TypeBroad incumbent
Description

Elsevier's broad clinical content platform covering drug information, clinical decision support, and evidence-based medicine across all specialties—a wider portfolio competitor with overlapping drug/clinical content but broader medical publishing footprint.

6Micromedex
TypeDirect peer
Description

Merative's drug reference and clinical decision support suite widely used by hospitals and pharmacists, providing comparable drug information, interaction checking, and IV compatibility tools to PEPID.

TypeEmerging player
Description

Image-based clinical decision support and differential diagnosis tool with AI-augmented image recognition, competing with PEPID's DDx Generator and serving emergency medicine, dermatology, and primary care clinicians.

TypeDirect peer
Description

Athenahealth's mobile-first drug reference and clinical tool for healthcare professionals, with overlapping drug interaction checking, pill identifier, and point-of-care clinical content targeted at similar clinician segments.

TypeDirect peer
Description

Wolters Kluwer's drug information and clinical decision support suite serving pharmacists and clinicians with drug interaction checking, IV compatibility, and dosing—directly overlapping PEPID Pharmacist Pro and drug database capabilities.

TypeDirect peer
Description

EBSCO's evidence-based clinical reference tool competing directly with PEPID across primary care, emergency medicine, and nursing specialties with similar specialty-suite content and clinical decision support.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PEPID

Clinical Decision Support Softwarepepid.com

PEPID is a privately held clinical decision support and medical reference software company that sells specialty drug databases, calculators, and clinical content subscriptions to healthcare professionals, students, and institutions across 159 countries.

What PEPID does

PEPID (PEPID, LLC) is a privately held clinical decision support and medical reference software company founded in 1994 by Dr. Mark Rosenbloom and headquartered in Evanston, Illinois. The company provides healthcare professionals — including emergency physicians, nurses, pharmacists, nurse practitioners, EMTs/paramedics, medical students, and residents — with point-of-care access to a curated clinical content platform comprising the PEPID Knowledgebase (PKB) drug database (13,000+ drug names covering U.S. and Canadian trade names, generics, OTCs, herbals, and supplements, cross-referenced against 100,000+ drug products and 900+ nutraceuticals), 3,000+ dosing and IV-drip calculators, 800+ medical calculators/scores, a 200+ entry lab manual, 750+ procedural videos, 1,800+ medical illustrations, 1,200+ radiographic images, a differential diagnosis generator, pill identifier, and IV compatibility checker. PEPID's content is peer-reviewed by an advisory board of 35+ board-certified physicians and pharmacologists and is produced in partnership with U.S. medical societies including ASHP, ACEP, AAEM, NAEMSE, NACNS, ONS, FPIN, and BEEM, with approximately 44% of content refreshed each calendar quarter.

The platform is delivered through three distribution channels: direct subscriptions via the PEPID Connect web portal, native iOS and Android mobile apps, and the Backbone by PEPID API layer for embedding drug interaction, IV compatibility, and clinical content into third-party EMR, EHR, HIS, HIE, and patient portal systems. Revenue is generated through individual professional subscriptions priced in the $100–$300 annual range (1-/2-/3-year tiers), lower-priced student and resident monthly tiers ($8–$25/month), add-on modules such as Patient Medication Education, Bedside Education, and PEPID CME, and undisclosed institutional volume licensing plus OEM/API licensing economics. The company markets primarily via a product-led growth motion (2-week free trials across all suites) supplemented by institutional sales outreach and society-driven brand endorsement, and reports reach across thousands of institutions in 159 countries. Leadership consists of founder-CEO Dr. Mark Rosenbloom, who also serves as Editorial Director, and CTO Edward Reynolds; the company has no disclosed external funding rounds and operates with an 11–50 person headcount.

PEPID firmographics

Firmographics
Name
PEPID
Legal name
PEPID, LLC
Website
https://pepid.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Short description
PEPID is a privately held clinical decision support and medical reference software company that sells specialty drug databases, calculators, and clinical content subscriptions to healthcare professionals, students, and institutions across 159 countries.
Ownership category
akta.pro rank

PEPID industry classification

Industry
Product category
Clinical Decision Support Software
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAKAC
Pharmacy Information Systems (PIS) & Dispensing Workflow
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • Clinical decision support
  • Drug interaction checking
  • Medical reference software
  • Healthcare point-of-care
  • Clinical calculators

Where PEPID is headquartered

Location

Headquarters

HQ city
Phoenix
HQ country
United States
HQ region
North America

Offices1 record

Markets served

PEPID business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D

Revenue model

  1. Individual Subscriptions: Subscription-based model with annual, 2-year, and 3-year billing options for individual healthcare professionals across various specialties including emergency medicine, nursing, pharmacy, and primary care.
  2. Institutional Licenses: Volume-based institutional subscriptions for hospitals, health systems, and educational institutions with shared logins, IP authentication, or individual login options supporting unlimited concurrent users.
  3. API/Integration Licensing: Backbone by PEPID provides drug database and clinical content integration into EMR, EHR, HIS, and other health IT systems through API licensing.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEmergency Medicine Suite - Individual subscription for emergency physicians
SubscriptionAnnualPediatric Emergency Medicine Suite
SubscriptionAnnualPharmacist Pro with AHFS
SubscriptionAnnualEMS Plus NAEMSE - For EMTs and paramedics
SubscriptionMonthlyRN Student Clinical Companion
SubscriptionMonthlyEmergency Medicine - Resident/Monthly pricing
SubscriptionMonthlyPatient Medication Education Add-on
SubscriptionAnnualBedside Education Add-on
SubscriptionMonthlyAHFS Drug Information Essentials by PEPID
SubscriptionMonthlyRN Care Plan Pro
SubscriptionMonthlyClinical Rotation Companion for Medical Students

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

PEPID product offering

Product offering

Core offering

PEPID provides web-based and mobile point-of-care clinical decision support tools and drug information resources for healthcare professionals, institutions, and students. Its portfolio includes specialty medical suites (emergency medicine, nursing, pharmacy, primary care, EMS), clinical tools such as drug interaction checkers and dosing calculators, and the Backbone API platform for integrating clinical content into EMR/EHR systems.

Product overview

PEPID offers a comprehensive clinical decision support platform comprising multiple specialized product suites for healthcare professionals across various medical specialties. The portfolio includes: EM Complete (new flagship combining adult and pediatric emergency medicine with integrated CME), Emergency Medicine Suite, Pediatric Emergency Medicine Suite, Primary Care Plus Ambulatory Care, Professional Nursing Suite, Critical Care Nursing Suite, Oncology Nursing Suite, Gerontological Nursing Suite, Clinical Rotation Companion, RN Student Clinical Companion, RN Care Plan Pro, Pharmacist Pro with AHFS, AHFS Drug Information Essentials, Portable Drug Companion, and EMS Plus NAEMSE. Supporting modules include Bedside Education, Patient Medication Education, and PEPID CME. Core tools and features include Drug Interactions Checker, IV Compatibility Checker, Dosing & Medical Calculators, Pill Identifier, Lab Manual, Medical Videos (750+), Illustrations & Radiographic Images (1,800+ illustrations, 1,200+ images), Notes & Favorites, and Differential Diagnosis Generator. Access is available via PEPID Connect (online), mobile apps (iOS/Android), and system integration through Backbone by PEPID. Founded in 1994, PEPID maintains approximately 44% content updates quarterly through an aggressive editorial cycle with peer-reviewed content from board-certified specialists.

Differentiator

Problem solved

Functional benefit

Brands

  • PEPID Connect: Online clinical decision support platform accessible from any PC or Apple computer with automatic content updates
  • Backbone by PEPID
  • PEPID Knowledgebase (PKB)
  • EM Complete
  • PEPID CME

Products and services

  • Emergency Medicine Suite

Quantifiable outcome

  • PEPID's Drug Interactions Checker is backed by the PEPID Knowledgebase (PKB) which houses the largest drug database on the market, continuously reviewed and updated in close partnership with ASHP
  • +2 more outcomes

Companies that use PEPID

Customer profile

Named customers6 records

Segments8 records

Ideal customer profiles3 records

PEPID technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature8 records

PEPID partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and secondary.

  • American College of Emergency Physicians (ACEP)coreStrategic or Co-development PartnerACEP is a content partnership providing evidence-based essentials, guidelines, and high-resolution multimedia for PEPID's emergency medicine databases and suites.
  • American Academy of Emergency Medicine (AAEM)coreStrategic or Co-development PartnerAAEM provides content partnership for emergency medicine reference materials, protocols, and evidence-based guidelines integrated into PEPID's clinical decision support suites.
  • American Society of Health Systems Pharmacists (ASHP)coreStrategic or Co-development PartnerASHP partnership provides the foundation for PEPID's industry-leading drug database with continuous review and updates to ensure accuracy and comprehensiveness of drug information.
  • National Association of EMS Educators (NAEMSE)coreStrategic or Co-development PartnerNAEMSE collaborated with PEPID to develop EMS Plus NAEMSE, providing complete emergency medicine reference, drug database with toxicology section, emergency protocols and evidence-based information specifically designed for pre-hospital emergency care providers.
  • National Association of Clinical Nurse Specialists (NACNS)coreStrategic or Co-development PartnerNACNS partnered with PEPID to develop specialized nursing suites including Critical Care Nursing Suite (RNCC) and Gerontological Nursing Suite (RN Gero), providing evidence-based considerations and specialized content for clinical nurse specialists.
  • Oncology Nursing Society (ONS)coreStrategic or Co-development PartnerONS developed PEPID Oncology Nursing Suite (RN ONS) to simplify complex cancer care and strengthen evidence-based nursing with the latest PEP cards, NANDA-I considerations, drug information, and clinical content.
  • Family Physicians Inquiries Network (FPIN)secondaryStrategic or Co-development PartnerFPIN provides the latest peer-reviewed Clinical Inquiries and PURLs integrated into PEPID's Primary Care Plus and Clinical Rotation Companion suites for evidence-based clinical decision support.
  • BEEM (Better Evidence and Guidelines in Emergency Medicine)secondaryStrategic or Co-development PartnerBEEM provides evidence-based essentials and guidelines integrated into PEPID's emergency medicine and pediatric emergency medicine databases.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

PEPID competitors and assessment

Company assessment

Direct peers

  • UpToDate: Wolters Kluwer's evidence-based clinical decision support platform serving physicians, nurses, and healthcare professionals across specialties with similar point-of-care content and drug reference functionality.
  • Medscape: WebMD's free clinical reference platform offering drug information, clinical calculators, and decision support to physicians, with overlapping user base and similar point-of-care use cases despite free/ad-supported model.
  • Micromedex: Merative's drug reference and clinical decision support suite widely used by hospitals and pharmacists, providing comparable drug information, interaction checking, and IV compatibility tools to PEPID.
  • Epocrates: Athenahealth's mobile-first drug reference and clinical tool for healthcare professionals, with overlapping drug interaction checking, pill identifier, and point-of-care clinical content targeted at similar clinician segments.
  • Lexicomp: Wolters Kluwer's drug information and clinical decision support suite serving pharmacists and clinicians with drug interaction checking, IV compatibility, and dosing—directly overlapping PEPID Pharmacist Pro and drug database capabilities.
  • DynaMed: EBSCO's evidence-based clinical reference tool competing directly with PEPID across primary care, emergency medicine, and nursing specialties with similar specialty-suite content and clinical decision support.

Emerging players

  • OpenEvidence: AI-native clinical decision support platform using large language models for medical reference, representing the emerging conversational AI threat to traditional content-database CDS tools like PEPID.
  • Isabel Healthcare: Differential diagnosis decision support tool that directly competes with PEPID's Differential Diagnosis Generator (DDx) functionality, focused on accelerating diagnostic accuracy for clinicians at point-of-care.
  • VisualDx: Image-based clinical decision support and differential diagnosis tool with AI-augmented image recognition, competing with PEPID's DDx Generator and serving emergency medicine, dermatology, and primary care clinicians.

Broad incumbents

  • ClinicalKey: Elsevier's broad clinical content platform covering drug information, clinical decision support, and evidence-based medicine across all specialties—a wider portfolio competitor with overlapping drug/clinical content but broader medical publishing footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

PEPID social profiles

Digital presence

PEPID financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PEPID leadership team

Management profile

Number of profiles

Profiles2 records

PEPID funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PEPID M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PEPID

What does PEPID do?

PEPID provides web-based and mobile point-of-care clinical decision support tools and drug information resources for healthcare professionals, institutions, and students. Its portfolio includes specialty medical suites (emergency medicine, nursing, pharmacy, primary care, EMS), clinical tools such as drug interaction checkers and dosing calculators, and the Backbone API platform for integrating clinical content into EMR/EHR systems.

Is PEPID a public or private company?

PEPID is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PEPID founded?

PEPID was founded in 1994. It employs 11 to 50 people.

Where is PEPID based?

PEPID is headquartered in Phoenix, United States, in the North America region.

How does PEPID make money?

Three revenue lines are on record. Individual Subscriptions are the primary driver. The others are institutional Licenses and API/Integration Licensing.

Who are PEPID's main competitors?

Direct peers on record are UpToDate, Medscape, Micromedex, Epocrates, Lexicomp and DynaMed. Emerging players are OpenEvidence, Isabel Healthcare and VisualDx. ClinicalKey is listed as a broad incumbent.

Does PEPID have an API?

Yes. Robust APIs enable alert customization in any HIT system according to interaction severity, patient history, custom drug lists, and institutional protocols. APIs allow integration of drug interaction checking, IV compatibility, pill identification, medical calculators, lab manual, medical videos, illustrations, and notes/favorites into EMR, HIS, or patient portal systems via the PEPID Knowledge Base (PKB). Developer documentation is at trybackbone.com.

What industry is PEPID in?

PEPID's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAKAC, Pharmacy Information Systems (PIS) & Dispensing Workflow. Its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PepidThe Future of Genomic MedicineThe article discusses the integration of genomic medicine into clinical practice, highlighting advancements in technologies like next-generation sequencing and CRISPR that enable personalized treatments and early disease detection. It outlines opportunities such as improved drug development and patient outcomes, while identifying challenges including ethical concerns, high costs, and regulatory complexities. PEPID PGX is introduced as a specific tool designed to support healthcare providers in integrating pharmacogenomics into their workflows.GlobeNewswireWave Medical Becomes PEPID InternationalPEPID announced that its partner Wave Medical will be rebranded as PEPID International to support growth outside the US and Canada. The company's drug database now covers 38 countries, positioning it as the largest and most authoritative global drug database.GlobeNewswireEase of Access to Medication, Treatment and Diagnosis Unveiled by PEPID at HIMSS13PEPID unveiled a patient-facing clinical decision support tool at HIMSS13, providing access to medication, treatment, and diagnosis information. The tool, integrated via Infobutton, meets Meaningful Use 2 objectives and is HL7 compliant. It includes drug interaction warnings and a pill identifier.GlobeNewswirePEPID Delivers Infobutton SolutionPEPID introduced its Infobutton, a one-click tool giving healthcare teams access to clinical, lab, and drug reference materials. The HL7-compliant solution integrates with EHRs and patient portals, and PEPID will demonstrate it at HIMSS13 in New Orleans.GlobeNewswirePEPID Bridges Disease and Treatment Data, Responds to Industry DemandsPEPID announced it is the first data provider to let healthcare professionals search for medications based on a patient's diagnosis and receive alerts for hazardous treatments. The company added drug-indication and drug-contraindication coding to its clinical decision support resources, including drug-to-disease checkers that alert providers when a medication should not be used due to underlying conditions or procedures.GlobeNewswirePepid Adds Canadian Drug Product Database, Identification NumbersPEPID announced it expanded its Canadian medical resources to include the Drug Product Database and Drug Identification Numbers. The database covers approximately 15,000 drug products and can be integrated into healthcare information systems. The addition supports clinicians with drug information for better-informed patient care.GlobeNewswirePEPID Enhances Drug Data With Pediatric and Adult Dose RangesPEPID announced adding pediatric and adult maximum dosing ranges to its Knowledge Base, including weight- and age-based parameters. The module provides alerts for dosing outside ranges and supports meaningful use reimbursements. Hospitals can integrate the information via PEPID's tools.GlobeNewswirePEPID Introduces Electronic NANDA Diagnosis to Nursing Schools and StudentsPEPID announced a partnership to integrate the 2012-2014 NANDA Diagnosis textbook into its RN Student Clinical Companion software, delivering it electronically to nursing students and schools. The text is available on iPad, iPhone, Android, BlackBerry, and online, and RN Student is required in over 200 nursing schools.GlobeNewswireQuebec Association of Emergency Physicians Provides PEPID to All MembersPEPID announced a partnership with the Quebec Association of Emergency Physicians to provide its PEPID Emergency Medicine mobile app to all AMUQ members. Members receive a one-year subscription usable on iPhone, iPad, Android, or BlackBerry devices, with subscriptions distributed upon membership renewal starting January 2012.GlobeNewswirePEPID Names Two New ExecutivesPEPID announced two new executives: John D. Aikman as Canadian managing director and Dr. Farhan Hameed as editorial director. Aikman brings eHealth experience from cma.ca, while Hameed previously taught medical informatics and practiced psychiatry. Both will support PEPID's mission to improve patient care and reduce medication errors.